Search results
Trulicity, Ozempic, other diabetes drugs in short supply at Erie-area pharmacies
Erie Times News via Yahoo News· 5 months agoPeople with diabetes who take injectable medications like Trulicity and Ozempic have been scrambling...
Trulicity vs. Ozempic: What's the Difference?
Verywell Health via Yahoo News· 12 months agoThe most common type of diabetes, type 2 diabetes mellitus, happens when blood glucose levels (blood sugar) become too high. As a consequence of type 2...
What Is Severe Insulin-Resistant Diabetes (SIRD)
Verywell Health via Yahoo News· 1 year agoMedically reviewed by Danielle Weiss, MD Severe insulin-resistant diabetes (SIRD) is a subgroup of type 2 diabetes. While symptoms of SIRD are the same...
Europe to face shortage of Lilly's diabetes drug through September
Reuters via Yahoo News· 10 months agoLike rival Novo Nordisk, Eli Lilly has also been struggling to meet high demand for its diabetes...
Will Acquisitions Help Novo Nordisk (NVO) Combat Stiff Rivalry?
Zacks via Yahoo Finance· 2 years agoDenmark-based Novo Nordisk A/S NVO has one of the broadest diabetes portfolios in the industry. The...
This TikTok Weight Loss Trend Might Be Causing A Shortage Of A Type 2 Diabetes Drug
21 Ninety via Yahoo News· 2 years agoTikTok has been taking the world by storm, but it has also ignited a lot of extreme trends....
Lilly sales surge on obesity, diabetes drug demand
BioPharma Dive via Yahoo Finance· 4 months agoSales of Eli Lilly’s diabetes drug Mounjaro exceeded $5 billion in 2023, its first full year on the market, the company said Tuesday, in the latest sign...
Game changers for diabetics
The Ledger via Yahoo News· 2 years agoGLP-1 Agonists and SGLT-2 Inhibitors May Be Game Changers for Diabetics By Robin Williams Adams Your Health Correspondent More than 50 brands of...
Eli Lilly Dives After A 'Bump In The Road' Shakes Its Newest Diabetes Drug
Investor's Business Daily· 1 year agoEli Lilly experienced a "bump in the road" for its newest diabetes treatment, Mounjaro, an analyst...
Lilly hikes revenue forecast by $2B as GLP-1 drug sales climb
BioPharma Dive via Yahoo Finance· 1 month agoDive Brief: Eli Lilly raised its revenue forecast for the year by $2 billion as sales of its GLP-1...